November 6, 2014 / 1:17 PM / in 3 years

BUZZ-Aeterna Zentaris Inc: To open at record low after FDA rejection

** Canadian company’s U.S.-listed shares set to open down 53 pct at a record low of 59 cents

** Says U.S. Food and Drug Administration rejected its experimental growth hormone diagnostic test

** FDA asks Aeterna to conduct a new trial to demonstrate the effectiveness of macimorelin, the company’s experimental test designed to determine if adults’ pituitary glands are secreting enough growth hormone

** Up to Wednesday’s close, stock had fallen 7 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below